Founded in 1998, Ami Polymer Pvt. Ltd. (APPL) has emerged as a trailblazing Indian manufacturer of silicone elastomeric and advanced polymeric solutions. The company delivers cutting-edge technologies for fluid transfer, sealing, and contamination control, serving a wide spectrum of industries—ranging from biopharmaceuticals and pharmaceuticals to medical devices, laboratories, food and beverages, and engineering—across global markets.
With world-class ISO Class VII and VIII cleanroom facilities, APPL operates under rigorous quality and safety standards. The company holds a comprehensive suite of certifications, including ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, and ISO 13485:2016. To align with evolving global regulatory frameworks, APPL has also adopted the BPOG extractables program, reinforcing its commitment to compliance and innovation.
In a major stride forward, APPL inaugurated a sprawling 250,000 sq. ft. manufacturing plant in Silvassa in April 2024. This facility includes a 60,000 sq. ft. cleanroom zone, significantly bolstering production capabilities. The company’s workforce, now exceeding 600 professionals, comprises a robust mix of skilled rubber technologists, biotechnologists, and engineers. Over the years, APPL has engineered more than 5,000 customized products, catering to a loyal global clientele of over 3,000 satisfied customers.
Its diverse product portfolio includes silicone tubings, hoses, inflatable seals, gaskets, and single-use assemblies—each crafted to meet the stringent demands of sectors such as pharmaceuticals, biotech, food processing, medical, and engineering. APPL’s unwavering focus on quality and innovation has earned prestigious accolades, including Excellence Awards from ASSOCHAM in 2016 and 2018.
Driven by a bold vision, APPL aspires to lead the global market in inflatable seals, pharma tubing, and silicone rubber implants, setting industry benchmarks through relentless research and product development. The company’s mission is clear: to collaborate with the life sciences community in delivering advanced polymer solutions that enable affordable, high-quality healthcare.
At Medical Fair India 2025, in an exclusive conversation with The Interview World, Anuj Singh, Deputy Manager – Global Healthcare Division, Ami Polymer, sheds light on the company’s innovations in medical-grade silicone products. He underscores their distinctive features, elaborates on the company’s sustainability-centric manufacturing processes, and shares a forward-looking perspective on upcoming innovations, growth strategies, and ambitious revenue targets.
Here are the key highlights from this insightful exchange.
Q: Can you elaborate on the range of silicone-based products developed by Ami Polymer and their key applications in medical domain?
A: We primarily specialize in medical-grade silicone raw materials, focusing on the development and manufacturing of implantable medical products across diverse categories, including gynecology, cardiovascular, and ENT applications. Our expansive product portfolio reflects a deep understanding of specialized healthcare needs.
In addition to silicone-based solutions, we also offer precision plastic molding and operate advanced Liquid Silicone Rubber (LSR) injection molding machines, enhancing our ability to deliver complex, high-performance components. Backed by robust in-house manufacturing capabilities, we efficiently produce a wide variety of products tailored to specific industry requirements.
Customization lies at the heart of our operations. We work closely with clients to develop bespoke solutions that align with their exact specifications, ensuring we not only meet but exceed their expectations with every delivery.
Q: Could you walk us through the range of products Ami Polymer has developed so far?
A: We offer a portfolio of over 5,000 molded products, reflecting the depth and versatility of our manufacturing expertise. Within this expansive range, we provide more than 100 specialized medical products, designed to meet the highest standards of safety and performance.
While the majority of these are made from medical-grade silicone, we also manufacture components using polypropylene (PP), polyvinyl chloride (PVC), polyvinylidene fluoride (PVDF), glass, and nylon. Additionally, we supply customized clamps and a wide array of precision-engineered parts. This diverse material selection allows us to cater to the complex and evolving needs of the medical and healthcare sectors with unmatched flexibility and reliability.
Q: What sets Ami Polymer’s products apart from those of your competitors in the Indian market?
A: Now, coming to what sets us apart—our unwavering commitment to quality. We deliver products that meet the highest standards while remaining remarkably affordable. This rare blend of excellence and accessibility gives us a distinct edge over the competition.
Q: Are your products specifically designed for the Indian market, or are you also catering to international clients? If so, could you share which countries you are currently exporting to?
A: We operate on two powerful fronts—we manufacture for the Indian market and export globally. Our reach extends to over 40 countries, reflecting the strength of our expansive distribution network and a diverse, loyal customer base.
Q: What sustainable practices does Ami Polymer incorporate in the manufacturing of its medical products?
A: Let’s turn to our sustainable solutions and current practices. We have established a fully in-house mold design and manufacturing process. Every product begins with a clean slate—we design it from scratch. Our team conducts thorough research, followed by detailed prototyping. From there, we move through a structured development cycle: initial prototypes, first samples, phase one trials, phase two trials, and finally, rigorous validation. This end-to-end approach ensures both precision and sustainability at every stage.
Q: What types of innovations are you currently working on to enhance or expand your existing product range?
A: Now, let’s talk about innovation—something we pursue relentlessly, driven directly by customer needs. Our customers are our compass. They show us what the market demands, what must be developed, and what potential revenue can be unlocked through the right solutions.
Guided by these insights, we develop highly specialized products. From an innovation standpoint, one of our key breakthroughs lies in medical implantables. We have successfully developed implants designed to remain in the human body for over 30 days. In fact, some of our products function effectively for 90 days, 180 days, or even as permanent implants.
Within India, very few players are venturing into permanent implant technology. We are already there—leading the way. We’re actively engaged in multiple projects with top-tier OEMs, co-developing and scaling advanced medical solutions. These collaborations not only drive innovation but also help us bring cutting-edge products to market at scale, unlocking long-term commercial value.
Q: Could you share Ami Polymer’s current revenue figures and the growth targets you are aiming to achieve over the next five to ten years?
A: Currently, we generate revenue exceeding ₹150 crore. Over the next five years, we aim to scale significantly and position the company to cross the ₹1,000 crore mark. This vision drives every strategic move we make today.
